Clinical Trial Update: Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update evaluating propranolol, carvedilol, and rosuvastatin for prevention of variceal bleeding in cirrhotic portal hypertension across Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Portal Hypertension
• Variceal Hemorrhage

Drugs mentioned

• CARVEDILOL (Carvedilol)
• Propranolol (propranolol)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Universidade Federal do Rio de Janeiro | Conditions: Cirrhosis, Portal Hypertension | Phase 2, Phase 3 | Status: UNKNOWN